JDRF One Walk® in Avon-by-the-Sea on Sunday, October 7 Expected to Draw More Than 3,000 Supporters
― JDRF NJ Metro & Rockland County Chapter aims to raise $600,000 for type 1 diabetes research ―
AVON-BY-THE-SEA, NJ, October, 7, 2018 ― JDRF One Walk will kick off its annual event in Avon-by-the-Sea on Sunday, October 7 at Avon-by-the-Sea Boardwalk, aiming to raise more than $600,000 to help fund critically needed type 1 diabetes (T1D) research. The event, organized by JDRF New Jersey Metro & Rockland County Chapter, is expected to attract more than 3,000 supporters, including teams representing local businesses, families, schools and other organizations. The event is one of approximately 200 JDRF One Walks nationwide that bring together hundreds of thousands of people each year who share JDRF’s vision to create a world without T1D.
Find out what's happening in Woodbridgefor free with the latest updates from Patch.
“Everyone who comes out to walk or support the event will bring us one step closer to turning Type One into Type None. This is a great activity for families and friends to get together in support of type 1 diabetes research, whether you know someone affected by T1D or just want to make a difference,” said Executive Director Jess Backofen. “We are grateful for the incredible support of the people of Avon-by-the-Sea, and supporters like Plymouth Rock Assurance, who are doing their part to make life better for more than 1.25 million people in the United States who have this serious disease.”
JDRF encourages people of all ages driven to support a great cause to participate in JDRF One Walk and enjoy a day of family-friendly fun, with games, activities, and local vendors. Pre-registration is recommended and on-site check-in begins at 8:30 AM, 601 Ocean Avenue. The entire JDRF One Walk will be approximately 3 miles long. To register and for more information on the walk, click here. Read about our Everyday Hero here.
Find out what's happening in Woodbridgefor free with the latest updates from Patch.
Type 1 diabetes is a chronic, life-threatening autoimmune disease that strikes children and adults at any age. In type 1 diabetes, the body's immune system destroys the cells that release insulin, eventually eliminating insulin production from the body. Type 1 diabetes requires rigorous 24/7 monitoring of blood glucose levels to avoid devastating complications. T1D onset is sudden and unpreventable, and it is unrelated to diet or lifestyle.
JDRF One Walk is the largest and most powerful peer-to-peer fundraising program in the world for T1D. Since 1992, the event has raised more than $1 billion for T1D research. This funding has enabled research on how to prevent, delay and ultimately cure T1D. It has led to life-changing drugs, treatments and devices, many of which have already moved into clinical trials and real-world testing.
JDRF gratefully acknowledges its local corporate partners for New Jersey Metro & Rockland County Chapter’s Walk, including Ascensia Diabetes Care, RWJBarnabas Health, Novo Nordisk, and BD.
###
About T1D
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin, a hormone that enables people to get energy from food. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, JDRF has invested more than $2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF